Zealand Pharma (NASDAQ:ZEAL) reported its Q1 earnings results on Thursday, May 12, 2022 at 08:00 AM.
Here's what investors need to know about the announcement.
Earnings
Zealand Pharma beat estimated earnings by 17.02%, reporting an EPS of $-0.78 versus an estimate of $-0.94.
Revenue was up $161.00 thousand from the same period last year.
Past Earnings Performance
Last quarter the company missed on EPS by $0.07 which was followed by a 16.75% drop in the share price the next day.
Here's a look at Zealand Pharma's past performance:
| Quarter | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
|---|---|---|---|---|
| EPS Estimate | -0.93 | -0.99 | -0.92 | -1.01 |
| EPS Actual | -1 | -0.73 | -1.11 | -0.94 |
| Revenue Estimate | 11.98M | 11.09M | 10.76M | 9.89M |
| Revenue Actual | 8.31M | 16.88M | 13.66M | 7.50M |
To track all earnings releases for Zealand Pharma visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
